JPRN-UMIN000031563尚未招募未知
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?" - CHANGE trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. End stage renal failure including eGFR<15ml/min/1.73m2 or dialytic therapy 2. Treated with SGLT2 inhibitor 3. Contraindications of SGLT2 inhibitor 4. Type 1 diabetes mellitus 5. The pregnant, breast feeder 6. BMI<18.5kg/m2
研究者
相似试验
已完成
不适用
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
已完成
4 期
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.CTRI/2019/02/017435SRM College of Pharmacy40
招募中
不适用
The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DMAFLD/NASHJPRN-UMIN000036560ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology30
已完成
不适用
The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease.onalcoholic fatty liver disease type 2 diabetes mellitusJPRN-UMIN000023044Kyoto prefetural University of Medicine20
已完成
不适用
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36